2025-12-04 - Analysis Report
Okay, here's a report summarizing the information you provided for Procter & Gamble (PG), followed by an analysis.

**Report: Procter & Gamble (PG)**

**1) Return vs. S&P 500 (VOO)**

*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation that manufactures and markets a wide range of branded consumer products.
*   **PG Cumulative Return:** 27.85%
*   **VOO Cumulative Return:** 100.36%
*   **Divergence:** -72.3 (Relative Divergence: 1.7)

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 21.0%  | 7.9%  | -8.0%  | 0.0  | 214.9  |
| 2016-2018  | 9.0%   | 67.3% | -6.0%  | 0.1  | 215.0  |
| 2017-2019  | 24.0%  | 70.4% | 2.0%   | 0.3  | 292.1  |
| 2018-2020  | 27.0%  | 78.8% | 4.0%   | 0.4  | 325.4  |
| 2019-2021  | 41.0%  | 78.8% | -5.0%  | 0.5  | 382.6  |
| 2020-2022  | 13.0%  | 79.4% | 13.0%  | 0.6  | 354.5  |
| 2021-2023  | 26.0%  | 79.4% | 24.0%  | 0.4  | 342.7  |
| 2022-2024  | 9.0%   | 79.4% | -12.0% | 0.4  | 392.1  |
| 2023-2025  | -16.0% | 80.1% | -81.0% | 0.2  | 342.5  |

**2) Recent Stock Price Fluctuations**

*   **Close:** 146.4273
*   **Last-market:** Price: 146.3, Previous Close: 145.86, Change: 0.3
*   **5-day SMA:** 147.4075
*   **20-day SMA:** 147.2919
*   **60-day SMA:** 150.8783

**3) Indicators and Signals**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 43.6999577204555
*   **PPO:** 0.0365
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -9.2 (Negative - indicating short-term decline)
*   **Expected Return (%):** 52.9 (Expected excess return compared to S&P 500 if invested long-term)

**4) Recent News & Significant Events:**

*   **Mixed Sentiment:** News articles reflect mixed sentiment. Some discuss Q1 FY26 earnings opinions and price decline. Recent articles highlight that the stock hit a 2-year low and CFO warnings about consumers. Other articles focus on investor interest and potential for a wake-up call.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.00)
*   **Target Price:** Average: 169.05, High: 186.00, Low: 148.00

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-24 | 2    | 22.39 B$     |
| 2025-04-24 | 1.58 | 19.78 B$     |
| 2025-01-22 | 1.94 | 21.88 B$     |
| 2024-10-18 | 1.65 | 21.74 B$     |
| 2025-10-24 | 1.65 | 21.74 B$     |

**6) Financial Information**

*   **Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-09-30 | $22.39B    | 51.37%        |
| 2025-06-30 | $20.89B    | 49.11%        |
| 2025-03-31 | $19.78B    | 50.98%        |
| 2024-12-31 | $21.88B    | 52.39%        |
| 2024-09-30 | $21.74B    | 52.06%        |

*   **Capital and Profitability:**

| Quarter    | Equity     | ROE   |
|------------|------------|-------|
| 2025-09-30 | $53.27B    | 8.92% |
| 2025-06-30 | $52.01B    | 6.95% |
| 2025-03-31 | $52.27B    | 7.21% |
| 2024-12-31 | $51.17B    | 9.05% |
| 2024-09-30 | $51.84B    | 7.64% |

**Analysis:**

*   **Underperformance vs. S&P 500:** PG has significantly underperformed the S&P 500. The large negative divergence highlights this, especially the recent decline indicated by the divergence change.
*   **Alpha & Beta:** The Alpha values indicate that PG often lags the market's overall return (negative Alpha), although there are some years where it outperforms. The Beta values are relatively low, meaning PG has historically been less volatile than the overall market.
*   **Moving Averages:** The short-term moving averages (5-day and 20-day) are slightly below the 60-day SMA, which *could* indicate a potential short-term downward trend or consolidation. However, the price is fluctuating around these averages.
*   **Technical Indicators:** The RSI is around 44, indicating neutral momentum, neither overbought nor oversold. The PPO is low which is also neutral.
*   **Investment Recommendation:** The Market Risk Indicator (MRI) suggests a "High Investment Recommended" rating. The "Hybrid Signal" points to a buy recommendation. The recent decline doesn't necessarily negate the long-term investment potential.
*   **News & Sentiment:** The recent news is a mixed bag, with concerns about consumer spending and price declines weighing against the company. These concerns seem to be short-term in nature.
*   **Analyst Consensus:** Analysts have a "Buy" consensus rating and a significantly higher average target price. This suggests analysts believe the stock is undervalued.
*   **Earnings:** Revenue and EPS are fluctuating.
*   **Financial Health:** PG maintains healthy profit margins (around 50%) and ROE.  Equity is also growing slightly. The business fundamentals seem strong.

**7) Comprehensive Analysis (Summary):**

Procter & Gamble appears to be facing some short-term headwinds. The underperformance relative to the S&P 500 is significant. Recent news highlights some concerns about consumer spending impacting the company.

However, several factors suggest potential long-term value:

*   **Strong Fundamentals:** PG has consistent revenue, profitability and ROE.
*   **Analyst Support:** Analysts generally have a "Buy" rating with a higher target price.
*   **High Investment Recommended:** The Market Risk Indicator suggests a "High Investment Recommended" rating.

**Overall Recommendation:** While the stock price is down and recent news is concerning, the underlying financials of P&G appear strong. Considering the analyst consensus and long-term potential based on fundamentals, a cautious buy strategy might be worth considering, especially if the stock price continues to decline. Investors should monitor the consumer spending trends impacting P&G's business in the near future.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.